booster shot

Bivalent COVID-19 booster vaccines remained effective this winter despite the emergence of new omicron subvariants that they weren’t designed to target, researchers have found.

The Food and Drug Administration is expected to authorize a second omicron-specific booster for people 65 and older and those with comprised immune systems sometime later this month.

The data support a single yearly dose of the COVID-19 bivalent booster vaccine for older adults and other groups vulnerable to severe disease, ACIP members say.

Nursing home residents who have received the COVID-19 bivalent booster shot are 30% to 50% less likely to become infected with SARS-CoV-2 than their fellow residents who haven’t gotten boosted, the...

In an effort to streamline COVID-19 protection, older adults and others vulnerable to severe disease would receive two annual shots of an updated vaccine, according to a plan to be evaluated on Thursday...

Policymakers should rethink their “stagnant” approach to booster shots, argue the researchers behind a new, first-of-its kind national study linking COVID-19 vaccination of nursing home staff to significantly...

New data and support materials are available for clinicians who want to encourage more residents and staff to get the updated COVID-19 booster shot.

Vaccine boosters appeared to play a key role in preventing COVID–19-associated morbidity and mortality across two large LTC systems.

The Food and Drug Administration has expanded the authorization for Novavax’s COVID-19 vaccine, the agency announced Wednesday.

Nursing home residents who received a second mRNA booster shot during omicron were much less likely to suffer severe COVID-19 outcomes than their peers who received only one dose, a new study shows.